This real-world Irish pharmacy study which was presented at European Association for the Study of Diabetes (EASD), explores how the use of cardiovascular, mental health and inflammation-related medicines changed after patients started liraglutide. Download the poster for an overview of the study design, key results and the potential wider impact of obesity treatment beyond weight loss.